Fundies.
English

Segment disclosures

Company overview

SELECTA BIOSCIENCES, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 17 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rnac:OperatingSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260806Open filing evidence
2026-01-01 – 2026-06-3078000 RestatedUSD20260806Open filing evidence
2026-01-01 – 2026-03-3178000 RestatedUSD20260430Open filing evidence
2025-01-01 – 2025-12-312797000 RestatedUSD20260309Open filing evidence
2025-07-01 – 2025-09-30452000 RestatedUSD20251106Open filing evidence
2025-01-01 – 2025-09-301850000 RestatedUSD20251106Open filing evidence
2025-04-01 – 2025-06-30298000 RestatedUSD20260806Open filing evidence
2025-01-01 – 2025-06-301398000 RestatedUSD20260806Open filing evidence
2025-01-01 – 2025-03-311100000 RestatedUSD20260430Open filing evidence
2024-01-01 – 2024-12-3138913000 RestatedUSD20260309Open filing evidence
2024-07-01 – 2024-09-30387000 RestatedUSD20251106Open filing evidence
2024-01-01 – 2024-09-3039672000 RestatedUSD20251106Open filing evidence
2024-04-01 – 2024-06-3033445000 RestatedUSD20250807Open filing evidence
2024-01-01 – 2024-06-3039285000 RestatedUSD20250807Open filing evidence
2024-01-01 – 2024-03-315840000 USD20250508Open filing evidence

Reporting Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rnac:ReportingSegmentsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-3138913000 RestatedUSD20250313Open filing evidence
2023-01-01 – 2023-12-3126004000 USD20250313Open filing evidence